Indicators of dementia disease progression in primary care: An electronic health record cohort study.
dementia
electronic health records
outcomes
primary care
prognosis
Journal
European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
revised:
17
12
2020
received:
23
07
2020
accepted:
20
12
2020
pubmed:
31
12
2020
medline:
13
8
2021
entrez:
30
12
2020
Statut:
ppublish
Résumé
The objectives were to assess the feasibility and validity of using markers of dementia-related health as indicators of dementia progression in primary care, by assessing the frequency with which they are recorded and by testing the hypothesis that they are associated with recognised outcomes of dementia. The markers, in 13 domains, were derived previously through literature review, expert consensus, and analysis of regional primary care records. The study population consisted of patients with a recorded dementia diagnosis in the Clinical Practice Research Datalink, a UK primary care database linked to secondary care records. Incidence of recorded domains in the 36 months after diagnosis was determined. Associations of recording of domains with future hospital admission, palliative care, and mortality were derived. There were 30,463 people with diagnosed dementia. Incidence of domains ranged from 469/1000 person-years (Increased Multimorbidity) to 11/1000 (Home Pressures). An increasing number of domains in which a new marker was recorded in the first year after diagnosis was associated with hospital admission (hazard ratio for ≥4 domains vs. no domains = 1.24; 95% confidence interval = 1.15-1.33), palliative care (1.87; 1.62-2.15), and mortality (1.57; 1.47-1.67). Individual domains were associated with outcomes with varying strengths of association. Feasibility and validity of potential indicators of progression of dementia derived from primary care records are supported by their frequency of recording and associations with recognised outcomes. Further research should assess whether these markers can help identify patients with poorer prognosis to improve outcomes through stratified care and targeted support.
Sections du résumé
BACKGROUND AND PURPOSE
The objectives were to assess the feasibility and validity of using markers of dementia-related health as indicators of dementia progression in primary care, by assessing the frequency with which they are recorded and by testing the hypothesis that they are associated with recognised outcomes of dementia. The markers, in 13 domains, were derived previously through literature review, expert consensus, and analysis of regional primary care records.
METHODS
The study population consisted of patients with a recorded dementia diagnosis in the Clinical Practice Research Datalink, a UK primary care database linked to secondary care records. Incidence of recorded domains in the 36 months after diagnosis was determined. Associations of recording of domains with future hospital admission, palliative care, and mortality were derived.
RESULTS
There were 30,463 people with diagnosed dementia. Incidence of domains ranged from 469/1000 person-years (Increased Multimorbidity) to 11/1000 (Home Pressures). An increasing number of domains in which a new marker was recorded in the first year after diagnosis was associated with hospital admission (hazard ratio for ≥4 domains vs. no domains = 1.24; 95% confidence interval = 1.15-1.33), palliative care (1.87; 1.62-2.15), and mortality (1.57; 1.47-1.67). Individual domains were associated with outcomes with varying strengths of association.
CONCLUSIONS
Feasibility and validity of potential indicators of progression of dementia derived from primary care records are supported by their frequency of recording and associations with recognised outcomes. Further research should assess whether these markers can help identify patients with poorer prognosis to improve outcomes through stratified care and targeted support.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1499-1510Subventions
Organisme : The Dunhill Medical Trust
ID : RPGF 1711/11
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Informations de copyright
© 2021 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
Références
Wittenberg R, Hu B, Barraza-Araiza L, Rehill A. Projections of older people with dementia and costs of dementia care in the United Kingdom, 2019-2040. London, UK: Care Policy and Evaluation Centre, London School of Economics and Political Science; 2019.
Abdi Z, Burns A. Championing of dementia in England. Alzheimer's Res Ther. 2012;4(5):1-3.
Department of Health. Living well with dementia: A national dementia strategy. London: Department of Health; 2009.
Dodd E, Cheston R, Ivanecka A. The assessment of dementia in primary care. J Psychiatr Ment Health Nurs. 2015;22(9):731-737.
Greaves I, Greaves N, Walker E, Greening L, Benbow SM, Jolley D. Gnosall primary care memory clinic: eldercare facilitator role description and development. Dementia. 2015;14(4):389-408.
Thyrian JR, Eichler T, Pooch A, et al. Systematic, early identification of dementia and dementia care management are highly appreciated by general physicians in primary care-results within a cluster-randomized-controlled trial (DelpHi). J Multidiscip Healthc. 2016;9:183.
Dening KH. Recognition and assessment of dementia in primary care. Br J Community Nurs. 2019;24(8):383-387.
Walters K, Hardoon S, Petersen I, et al. Predicting dementia risk in primary care: development and validation of the Dementia Risk Score using routinely collected data. BMC Med. 2016;14(1):6.
Ford E, Greenslade N, Paudyal P, et al. Predicting dementia from primary care records: a systematic review and meta-analysis. PLoS ONE. 2018;13(3):e0194735.
Campbell P, Rathod-Mistry T, Marshall M, et al. Markers of dementia-related health in primary care electronic health records. Aging Ment Health. 2020;24:1-11. https://doi.org/10.1080/13607863.2020.1783511
Burton C, Campbell P, Jordan K, Strauss V, Mallen C. The association of anxiety and depression with future dementia diagnosis: a case-control study in primary care. Fam Pract. 2013;30(1):25-30.
Brown A, Kirichek O, Balkwill A, et al. Comparison of dementia recorded in routinely collected hospital admission data in England with dementia recorded in primary care. Emerg Themes Epidemiol. 2016;13(1):11.
Browne J, Edwards DA, Rhodes KM, Brimicombe DJ, Payne RA. Association of comorbidity and health service usage among patients with dementia in the UK: a population-based study. BMJ Open. 2017;7(3):e012546.
Pham TM, Petersen I, Walters K, et al. Trends in dementia diagnosis rates in UK ethnic groups: analysis of UK primary care data. Clin Epidemiol. 2018;10:949.
Pujades-Rodriguez M, Assi V, Gonzalez-Izquierdo A, et al. The diagnosis, burden and prognosis of dementia: A record-linkage cohort study in England. PLoS ONE. 2018;13(6):e0199026.
Smith T, Noble M, Noble S, Wright G, McLennan D, Plunkett E. The English indices of deprivation 2015. London, UK: Department for Communities and Local Government; 2015.
Baker NL, Cook MN, Arrighi HM, Bullock R. Hip fracture risk and subsequent mortality among Alzheimer's disease patients in the United Kingdom, 1988-2007. Age Ageing. 2011;40(1):49-54.
Davies NM, Kehoe PG, Ben-Shlomo Y, Martin RM. Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias. J Alzheimers Dis. 2011;26(4):699-708.
Grant RL, Drennan VM, Rait G, Petersen I, Iliffe S. First diagnosis and management of incontinence in older people with and without dementia in primary care: a cohort study using The Health Improvement Network primary care database. PLoS Medicine. 2013;10(8):e1001505.
Imfeld P, Bodmer M, Schuerch M, Jick SS, Meier CR. Risk of incident stroke in patients with Alzheimer disease or vascular dementia. Neurology. 2013;81(10):910-919.
Cook M, Baker N, Lanes S, Bullock R, Wentworth C, Arrighi HM. Incidence of stroke and seizure in Alzheimer's disease dementia. Age Ageing. 2015;44(4):695-699.
Guthrie B, Clark SA, McCowan C. The burden of psychotropic drug prescribing in people with dementia: a population database study. Age Ageing. 2010;39(5):637-642.
Dennis M, Shine L, John A, et al. Risk of adverse outcomes for older people with dementia prescribed antipsychotic medication: a population based e-cohort study. Neurol Ther. 2017;6(1):57-77.
Lewis G, Werbeloff N, Hayes JF, Howard R, Osborn DP. Diagnosed depression and sociodemographic factors as predictors of mortality in patients with dementia. Br J Psychiatry. 2018;213(2):471-476.
Springate DA, Kontopantelis E, Ashcroft DM, et al. ClinicalCodes: an online clinical codes repository to improve the validity and reproducibility of research using electronic medical records. PLoS ONE. 2014;9(6):e99825.
Keele Medical Record Research website. www.keele.ac.uk/mrr. Accessed 6th July 2020.
General Medical Council. Treatment and care towards the end of life: good practice in decision making. www.gmc-uk.org/ethical-guidance/ethical-guidance-for-doctors/treatment-and-care-towards-the-end-of-life. Accessed 24th June 2020.
Gill SS, Bronskill SE, Normand SL, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 2007;146(11):775-786.
Banerjee S. The use of antipsychotic medication for people with dementia. Time for action. A report for the Minister of State for Care Services. Department of Health; 2009. http://webarchive.nationalarchives.gov.uk. Accessed June 24, 2020.
Modrego PJ, Lobo A. Determinants of progression and mortality in Alzheimer's disease: a systematic review. Neuropsychiatry (London). 2018;8(5):1465-1475.
Ralph SJ, Espinet AJ. Increased all-cause mortality by antipsychotic drugs: updated review and meta-analysis in dementia and general mental health care. J Alzheimer's Dis Rep. 2018;2(1):1-26.
McMichael AJ, Zafeiridi E, Passmore P, Cunningham EL, McGuinness B. Factors associated with mortality including nursing home transitions: a retrospective analysis of 25,418 people prescribed anti-dementia drugs in Northern Ireland. J Alzheimers Dis. 2020;73(3):1233.
Bandosz P, Ahmadi-Abhari S, Guzman-Castillo M, et al. Potential impact of diabetes prevention on mortality and future burden of dementia and disability: a modelling study. Diabetologia. 2020;63(1):104-115.
Lwi SJ, Ford BQ, Casey JJ, Miller BL, Levenson RW. Poor caregiver mental health predicts mortality of patients with neurodegenerative disease. Proc Natl Acad Sci. 2017;114(28):7319-7324.
McCoy TH Jr, Han L, Pellegrini AM, Tanzi RE, Berretta S, Perlis RH. Stratifying risk for dementia onset using large-scale electronic health record data: a retrospective cohort study. Alzheimer's Dement. 2020;16(3):531-540.
Rockwood K, Jones D, Wang Y, Carver D, Mitnitski A. Failure to complete performance-based measures is associated with poor health status and an increased risk of death. Age Ageing. 2007;36(2):225-228.
Lopez OL, Becker JT, Wisniewski S, Saxton J, Kaufer DI, DeKosky ST. Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2002;72(3):310-314.
Ku LJ, Li CY, Sun Y. Can persistence with cholinesterase inhibitor treatment lower mortality and health-care costs among patients with Alzheimer's disease? A population-based study in Taiwan. Am J Alzheimer's Dis Other Dement. 2018;33(2):86-92.
Mahmoudi R, Novella JL, Manckoundia P, et al. Is functional mobility an independent mortality risk factor in subjects with dementia? Maturitas. 2017;103:65-70.
de Sousa OV, Mendes J, Amaral TF. Nutritional and functional indicators and their association with mortality among older adults with Alzheimer's Disease. Am J Alzheimer's Disease Other Dement. 2020;35:1533317520907168. https://doi.org/10.1177/1533317520907168
Clegg A, Bates C, Young J, et al. Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing. 2016;45(3):353-360.
Sharma S, Mueller C, Stewart R, et al. Predictors of falls and fractures leading to hospitalization in people with dementia: a representative cohort study. J Am Med Dir Assoc. 2018;19(7):607-612.
International Consortium for Health Outcomes Measurement. The ICHOM Standard Set for Dementia 2016 (London, UK).
Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44(3):827-836.
McGuinness LA, Warren-Gash C, Moorhouse LR, Thomas SL. The validity of dementia diagnoses in routinely collected electronic health records in the United Kingdom: a systematic review. Pharmacoepidemiol Drug Saf. 2019;28(2):244-255.
Garcia-Ptacek S, Farahmand B, Kåreholt I, Religa D, Cuadrado ML, Eriksdotter M. Mortality risk after dementia diagnosis by dementia type and underlying factors: a cohort of 15,209 patients based on the Swedish Dementia Registry. J Alzheimers Dis. 2014;41(2):467-477.
Mueller C, Soysal P, Rongve A, et al. Survival time and differences between dementia with Lewy bodies and Alzheimer's disease following diagnosis: A meta-analysis of longitudinal studies. Ageing Res Rev. 2019;50:72-80.
Yaffe K, Fox P, Newcomer R, et al. Patient and caregiver characteristics and nursing home placement in patients with dementia. JAMA. 2002;287(16):2090-2097.
Gaugler JE, Duval S, Anderson KA, Kane RL. Predicting nursing home admission in the US: a meta-analysis. BMC Geriatrics. 2007;7(1):13.
Jones S, Howard L, Thornicroft G. ‘Diagnostic overshadowing’: worse physical health care for people with mental illness. Acta Psychiatr Scand. 2008;118(3):169-171.
Subramaniam H. Co-morbidities in dementia: time to focus more on assessing and managing co-morbidities. Age Ageing. 2019;48(3):314.
Apesoa-Varano EC, Barker JC, Hinton L. Curing and caring: the work of primary care physicians with dementia patients. Qual Health Res. 2011;21(11):1469-1483.
Macfarlane S, Cunningham C. The need for holistic management of behavioral disturbances in dementia. Int Psychogeriatr. 2017;29(7):1055-1058.